investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best

ACHILLION PHARMACEUTICALS
(00448Q201)

Funds Reporting Holdings of ACHILLION PHARMACEUTICALS according to 13F filings
Firm Name Shares Held / Principal Amount Market Value Option Report Period Effectiveness Date
Janus Capital Management LLC 4,392,988 $18,494k Mar 31, 2017 May 16, 2017
Panagora Asset Management Inc 1,492,489 $3,999k Jun 30, 2019 Aug 9, 2019
Teton Advisors Inc 10,000 $27k Jun 30, 2019 Aug 2, 2019
Acadian Asset Management LLC 15,914 $43k Jun 30, 2019 Aug 8, 2019
Renaissance Technologies LLC 3,007,000 $8,059k Jun 30, 2019 Aug 12, 2019
Jacobs LEVY Equity Management Inc 36,500 $98k Jun 30, 2019 Aug 13, 2019
Logan Capital Management Inc 20,000 $54k Jun 30, 2019 Jul 24, 2019
Rafferty Asset Management LLC 254,972 $683k Jun 30, 2019 Aug 9, 2019
Algert Global LLC 60,460 $162k Jun 30, 2019 Aug 14, 2019
Dafna Capital Management LLC 604,884 $1,621k Jun 30, 2019 Aug 14, 2019
Numeric Investors LLC 1,953,864 $5,627k Dec 31, 2017 Feb 14, 2018
LMCG Investments LLC 39,503 $273k Sep 30, 2015 Nov 4, 2015
QS Investors LLC 438,696 $1,176k Jun 30, 2019 Aug 14, 2019
RTW Investments LP 13,864,383 $37,157k Jun 30, 2019 Aug 14, 2019
MAK Capital One LLC 6,929,653 $18,571k Jun 30, 2019 Aug 14, 2019
Baker BROS Advisors LP 1,095,359 $2,936k Jun 30, 2019 Aug 14, 2019
Kerrisdale Advisers LLC 283,200 $759k Jun 30, 2019 Aug 14, 2019
Rock Springs Capital Management LP 2,950,000 $7,906k Jun 30, 2019 Aug 14, 2019
Candriam Luxembourg SCA 725,000 $1,934k Jun 30, 2019 Aug 1, 2019

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.

Copyright © 2019 by InvestingReview.org / All Rights Reserved.